NCT06034535View on ClinicalTrials.gov

CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

PHASE2RecruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Hematopoietic Organs; Disorder
Interventions
BIOLOGICAL

CD62L depleted donor lymphocyte infusion

Intravenous infusion of CD62L depleted donor lymphocytes

Trial Locations (1)

Unknown

RECRUITING

Hong Kong Children's Hospital, Hong Kong

All Listed Sponsors
lead

Hong Kong Children's Hospital

OTHER